Amrize (NYSE:AMRZ) Now Covered by Analysts at Stephens

Equities research analysts at Stephens initiated coverage on shares of Amrize (NYSE:AMRZ) in a report released on Friday,Benzinga reports. The firm set an “overweight” rating and a $60.00 price target on the stock. Stephens’ target price indicates a potential upside of 22.93% from the company’s current price.

Several other equities research analysts have also recently commented on AMRZ. JPMorgan Chase & Co. boosted their target price on Amrize from $52.00 to $60.00 and gave the stock an “overweight” rating in a report on Tuesday, August 26th. Royal Bank Of Canada lowered their price target on Amrize from $61.00 to $54.00 and set an “outperform” rating on the stock in a research report on Friday, August 8th. Barclays began coverage on Amrize in a research note on Tuesday, October 7th. They issued an “equal weight” rating on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amrize in a research note on Thursday, October 30th. Finally, Morgan Stanley set a $61.00 target price on Amrize and gave the stock an “overweight” rating in a report on Wednesday, October 29th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat, Amrize currently has an average rating of “Moderate Buy” and a consensus target price of $58.88.

Amrize Stock Performance

Shares of NYSE:AMRZ traded down $0.94 on Friday, hitting $48.81. The company’s stock had a trading volume of 1,017,579 shares, compared to its average volume of 3,632,467. The firm has a market capitalization of $27.00 billion and a P/E ratio of 26.50. The company has a quick ratio of 0.85, a current ratio of 1.38 and a debt-to-equity ratio of 0.42. Amrize has a 12 month low of $44.12 and a 12 month high of $56.29. The company’s 50-day moving average price is $50.25.

Amrize (NYSE:AMRZ) last posted its quarterly earnings data on Wednesday, October 29th. The company reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.01 by ($0.03). Amrize’s quarterly revenue was up 6.6% compared to the same quarter last year.

Insider Transactions at Amrize

In related news, CTO Roald Brouwer purchased 4,000 shares of the company’s stock in a transaction that occurred on Friday, October 31st. The shares were purchased at an average price of $51.77 per share, with a total value of $207,080.00. Following the purchase, the chief technology officer owned 9,000 shares of the company’s stock, valued at $465,930. This trade represents a 80.00% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Jan Philipp Jenisch acquired 55,000 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were bought at an average price of $52.64 per share, for a total transaction of $2,895,200.00. Following the acquisition, the chief executive officer owned 1,505,000 shares in the company, valued at approximately $79,223,200. This trade represents a 3.79% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 65,500 shares of company stock valued at $3,433,595 over the last three months.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in AMRZ. Acadian Asset Management LLC bought a new stake in Amrize in the second quarter worth approximately $25,590,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Amrize in the 2nd quarter valued at $62,646,000. Hiddenite Capital Partners LP bought a new stake in Amrize in the second quarter worth $12,388,000. TD Asset Management Inc acquired a new position in Amrize during the second quarter worth $8,190,000. Finally, Allianz Asset Management GmbH acquired a new position in Amrize during the second quarter worth $158,530,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.